Drug Trial Radar · NCT04629703
Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects
Last checked: Nov 20, 2026Latest source record: Aug 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
280
Actual
Start
Mar 25, 2021
Primary completion
Sep 5, 2022
Study completion Sep 5, 2022
Sponsor
- Lead sponsor
- Rigel PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Nov 16, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is a double-blind, randomized, placebo-controlled, multi-center, Phase 3 study to evaluate the efficacy and safety of fostamatinib in COVID-19 subjects.
Conditions
- Covid19
- SARS (Severe Acute Respiratory Syndrome)
- SARS Pneumonia
- SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere
- Pneumonia
- Pneumonia, Viral
Interventions
FostamatinibDrug
Fostamatinib (150 mg twice daily) for 14 days and Standard of Care
PlaceboDrug
Placebo (twice daily) for 14 days and Standard of Care
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of days on oxygen from randomization on Day 1 to Day 29Time frame: 29 days
Locations
47 sites in 4 countries. Site status is shown where the registry gives one.
University of California Irvine
Orange, California
George Washington University Hospital
Washington D.C., District of Columbia
Alternative Research Associates, LLC
Hialeah, Florida
Alternative Research Associates, LLC
Miami, Florida
Loyola University Medical School
Maywood, Illinois
Harvard Medical School- Bringham and Women's Hospital
Boston, Massachusetts
Henry Ford
Detroit, Michigan
Ascension Medical Group- St. John Clinic Infectious Disease
Tulsa, Oklahoma
Houston Methodist Research Institute
Houston, Texas
Hospital de Alta Complejidad Cuenta Alta
Buenos Aires, Argentina
Hospital Del Bicentenario - Dr. Luis Federico Leloir
Buenos Aires, Argentina
Clinica Zabala
Buenos Aires, Argentina
Clinica Adventista Belgrano
Buenos Aires, Argentina
Clinica Monte Grande
Buenos Aires, Argentina
Hospital de Infecciosas Dr.Francisco Javier Muñiz
Buenos Aires, Argentina
Sanatorio Guemes
Buenos Aires, Argentina
Sanatorio Sagrado Corazon
Buenos Aires, Argentina
Hospital San Roque
Córdoba, Argentina
Sanatorio Mayo Privado
Córdoba, Argentina
Corporacion Medica de General San Martin
San Martín, Buenos Aires, Argentina
Clinica Chutro
Córdoba, CP, Argentina
Hospital Lencinas
Godoy Cruz, Mendoza Province, Argentina
Hospital das Clínicas da Universidade Federal de Goiás (HC/UFG)
Goiânia, Goiás, Brazil
Hospital Luxenburgo-Associação Mário Penna
Belo Horizonte, Minas Gerais, Brazil
Hosp. Angelina Caron
Campina Grande do Sul, Paraná, Brazil
Hospital Universitario de Maringa
Maringá, Paraná, Brazil
Irmandade da Santa Casa de Misericórdia de Porto Alegre - ISCMPA
Porto Alegre, Rio Grande do Sul, Brazil
Hospital des clinicas de porto alegre - Centro de pequisas clinicas
Porto Alegre, Rio Grande do Sul, Brazil
Complexo de Prevenção, Diagnóstico, Terapia e Reabilitação Respiratória LTDA
Blumenau, Santa Catarina, Brazil
Hospital Alemão Oswaldo Cruz (HAOC)
Bela Vista, São Paulo, Brazil
Hospital Universitário São Francisco na Providência de Deus
Bragança Paulista, São Paulo, Brazil
Pontificia Universidade Catolica de Campinas (PUC-CAMP) - Hospital e Maternidade Celso Pierro (HMCP)
Campinas, São Paulo, Brazil
Hospital Bandeirantes (LeForte)
Liberdade, São Paulo, Brazil
Fundação Faculdade Reg. de Med de SJRP
São José do Rio Preto, São Paulo, Brazil
Clinica de Alergia Martti Antila S/S Ltda
Sorocaba, São Paulo, Brazil
Hospital Cardiologica Aguascalientes
Aguascalientes, Mexico
Icaro Investigaciones en Medicina
Chihuahua City, Mexico
Nuevo Hospital Civil de Guadalajara
Guadalajara, Mexico
Centro Medico Issemym Toluca
Metepec, Mexico
Hospital Ángeles Roma
México, Mexico
Showing 40 of 47 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.